However, the major strength of our study is being the first Asian report, to demonstrate the significance of Lp(a) in patients hospitalised with IHD, i.e. a very high-risk patient group, using the uniform measurement using a relatively isoform-insensitive assays that quantifies Lp(a) in molar rather than mass concentrations. This evidence concerns the gene LPA and myocardial ischemia.